CMS: COVID-19 waivers to remain in effect through May 11
If President Biden signs as expected Congress’ joint resolution ending the COVID-19 national emergency immediately, the Centers for Medicare & Medicaid Services’ COVID-19 waivers and flexibilities will remain in place through May 11 as planned, CMS announced today. The Biden Administration in January announced plans to end the COVID-19 national and public health emergencies on May 11. Congress’ joint resolution cleared the Senate this week after passing the House Feb. 1.
Related News Articles
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…
Headline
The Senate Health, Education, Labor and Pensions Committee today 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333),…
Headline
The Food and Drug Administration’s vaccine advisory committee June 15 voted unanimously to recommend updating the current COVID-19 vaccine composition for…
Headline
The first data on the safety of a third mRNA COVID-19 vaccine dose among young children show that a third dose is safe for children ages 6 months to 5 years…
Headline
The Food and Drug Administration authorized for marketing the first at-home over-the-counter test for COVID-19 using a traditional premarket review…